Corona Remedies Executive and Leadership Team

Bhavin Bhagat, the Chief Financial Officer at Corona Remedies, directs all fiscal planning and capital allocation strategies. Managing the financial health of this pharmaceutical manufacturing entity, the Chief Financial Officer oversees budgeting, risk assessment, and long-term investment portfolios. Bhagat ensures alignment between fiscal performance and the broader corporate mission of delivering high-quality medical products. By optimizing cost structures and revenue streams, the Chief Financial Officer supports sustainable growth across international markets. This leadership role involves constant collaboration with the Board to maintain transparency and regulatory compliance. Through rigorous financial oversight, Bhavin Bhagat secures the necessary resources for research and development initiatives. Ultimately, the Chief Financial Officer drives the economic stability required for the company to maintain a competitive edge in the complex pharmaceutical landscape.

Bhaven Shah, the President at Corona Remedies, directs the overarching corporate strategy and internal organizational development. Focusing on the core manufacturing mission, the President oversees the alignment of production capabilities with market demand. Shah drives initiatives to improve operational efficiency and quality control standards across all pharmaceutical lines. By fostering a culture of excellence, the President ensures that internal processes support the company's long-term growth objectives. This leadership role involves managing cross-functional teams to streamline product development cycles and enhance market responsiveness. Bhaven Shah coordinates with other executive leaders to maintain a unified vision for the organization. Through strategic oversight of internal operations, the President strengthens the company's position as a reliable manufacturer, ensuring that every product meets rigorous industry standards for safety and efficacy.

Vijay Charlu, the President at Corona Remedies, directs the expansion of manufacturing capacity and supply chain logistics. Focusing on the physical distribution and procurement networks, the President oversees the scaling of production facilities to meet international pharmaceutical requirements. Charlu drives the optimization of logistics to ensure timely delivery of medical products across diverse geographic regions. By managing vendor relationships and raw material sourcing, the President maintains the integrity of the manufacturing pipeline. This leadership role involves coordinating with regulatory bodies to ensure compliance with global manufacturing standards. Vijay Charlu works closely with the executive team to align production output with strategic market entry plans. Through the management of complex supply chain operations, the President ensures the company maintains a consistent and reliable supply of essential pharmaceutical products.

Sangeeta Thaker, the Global President, Business at Corona Remedies, directs all international market expansion and commercial partnerships. Overseeing the growth of the pharmaceutical portfolio in emerging and established markets, the Global President, Business drives revenue generation through strategic alliances. Thaker manages the commercial strategy to ensure the company's products reach a broader patient base globally. By analyzing market trends and competitive dynamics, the Global President, Business identifies new opportunities for product placement and brand development. This leadership role involves constant engagement with international stakeholders to foster long-term business relationships. Sangeeta Thaker coordinates with regional teams to adapt commercial approaches to local regulatory and cultural environments. Through the execution of aggressive business development plans, the Global President, Business secures the company's footprint as a major player in the global pharmaceutical industry.

Narinder Sagar, the Chief Information Officer at Corona Remedies, architects the digital infrastructure supporting pharmaceutical manufacturing operations. Overseeing data security, enterprise software integration, and technological innovation, the Chief Information Officer ensures seamless connectivity across all production facilities. Sagar drives the digital transformation agenda to enhance manufacturing efficiency and supply chain visibility. By implementing advanced analytics, the Chief Information Officer enables data-driven decision-making throughout the organization. This leadership role requires constant coordination with operational teams to protect intellectual property and maintain robust cybersecurity protocols. Narinder Sagar manages the technological roadmap to support rapid scaling in global markets. Through the deployment of cutting-edge systems, the Chief Information Officer optimizes internal workflows and strengthens the overall digital footprint of the company within the competitive pharmaceutical sector.